News
05-12-2011, 04:50 AM
Biocept, Inc., a privately-held laboratory testing company focused on the detection, enumeration and analysis of circulating tumor cells (CTCs) in cancer patients, today announced the publication of a paper describing the identification of different CTC phenotypes using its proprietary Cell Enrichment and Extraction platform.
More... (http://www.news-medical.net/news/20110512/Biocepts-paper-describes-identification-of-different-CTC-phenotypes-in-cancer-patients.aspx)
More... (http://www.news-medical.net/news/20110512/Biocepts-paper-describes-identification-of-different-CTC-phenotypes-in-cancer-patients.aspx)